CRANBURY, N.J.--(BUSINESS WIRE)--Oct. 30, 2018--
Kylie Mitchell, Ph.D., a leading scientist and minerals expert with
Innophos Holdings Inc. (NASDAQ:IPHS), will present “The Science Behind
Chelated Minerals for Supplementation” at SupplySide West 2018.
This press release features multimedia. View the full release here:
(Photo: Business Wire)
Through her presentation, Dr. Mitchell will provide attendees with an
insider’s view into the characterization of organically bound and
chelated minerals and how they offer multiple functional advantages and
increased bioavailability across a wide range of mineral categories,
including magnesium, calcium and zinc.
Taking place from November 6 – 10 at the Mandalay Bay Resort & Casino in
Las Vegas, NV, SupplySide West is an annual trade show and educational
forum that brings together more than 16,000 ingredient buyers and
suppliers from the dietary supplement, beverage, functional food,
personal care and sports nutrition industries.
Dr. Mitchell’s presentation is scheduled for Thursday, November 8 from
12:30pm – 12:50pm in the Exhibitor Presentation Theater located on the
Innophos will be at booth #2758 where it will demonstrate its
growing portfolio of customized nutrition blends, branded ingredients,
and high-performance minerals that improve quality of life and respond
to consumer demand.
About the Company
Innophos is a leading international producer of specialty ingredient
solutions that deliver far-reaching, versatile benefits for the food,
health, nutrition and industrial markets. We leverage our expertise in
the science and technology of blending and formulating phosphate salts,
minerals, enzymes and botanical based ingredients to help our customers
offer products that are tasty, healthy, nutritious and economical.
Headquartered in Cranbury, New Jersey, Innophos has manufacturing
operations across the United States, in Canada, Mexico and China. For
more information, please visit www.innophos.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181030005068/en/
Source: Innophos Holdings, Inc.Innophos Holdings Inc.
Sharon Merrill Associates